Table 2. Number of Studies Using Control Measures for MDROs Employed in Studies Performed in Healthcare Settings, 1982-2005

Management of Multidrug-Resistant Organisms in Healthcare Settings (2006)

Format Change [February 2017]

Update or clarification r17The format of this section was changed to improve readability and accessibility. The content is unchanged.

Number and percent of studies for each type of MDRO.
Focus of MDRO Study MDR-GNB (n=30)

No. (%)

MRSA (n=35)

No. (%)

VRE (n=39)

No. (%)

Education of staff, patients or visitors 19 (63) 11 (31) 20 (53)
Emphasis on handwashing 16 (53) 21 (60) 9 (23)
Use of antiseptics for handwashing 8 (30) 12 (36) 16 (41)
Contact Precautions or glove use α 20 (67) 27 (77) 34 (87)
Private Rooms 4 (15) 10 (28) 10 (27)
Segregation of cases 4 (15) 3 (9) 5 (14)
Cohorting of Patients 11 (37) 12 (34) 14 (36)
Cohorting of Staff 2 (7) 6 (17) 9 (23)
Change in Antimicrobial Use 12 (41) 1 (3) 17 (44)
Surveillance cultures of patients 19 (63) 34 (97) 36 (92)
Surveillance cultures of staff 9 (31) 8 (23) 7 (19)
Environmental cultures 15 (50) 14 (42) 15 (38)
Extra cleaning & disinfection 11 (37) 7 (21) 20 (51)
Dedicated Equipment 5 (17) 0 12 (32)
Decolonization 3 (10) 25 (71) 4 (11)
Ward closure to new admission or to all patients 6 (21) 4 (12) 5 (14)
Other miscellaneous measures 6 (22) β 9 (27) χ 17 (44) δ

α Contact Precautions mentioned specifically, use of gloves with gowns or aprons mentioned, barrier precautions, strict isolation, all included under this heading

β includes signage, record flagging, unannounced inspections, selective decontamination, and peer compliance monitoring (1 to 4 studies employing any of these measures)

χ includes requirements for masks, signage, record tracking, alerts, early discharge, and preventive isolation of new admissions pending results of screening cultures (1 to 4 studies employing any of these measures)

δ includes computer flags, signage, requirement for mask, one-to-one nursing, changing type of thermometer used, and change in rounding sequence (1 to 7 studies employing any of these measures)

References for Table

MDR-GNBs: (6, 8, 9, 11, 16, 38, 174, 175, 180, 209, 210, 213-215, 218, 334, 388, 406, 407)

MRSA: (68, 89, 152, 153, 165-173, 183, 188, 194, 204, 205, 208, 240, 269, 279, 280, 289, 304,
312, 327, 365, 392, 397, 408-412)